Table 4. Clinical data of patients . No... | American Society of Hematology

Table 4.

Clinical data of patients

	No substitution at position 116	Substitution at position 116	P
Patients
No.	63	37
Median age (y)	26	29	.6^4-150
Donors
Median age (y)	37	39	.2^4-150
Interval diagnosis-transplantation (d)	868	833	.6^4-150
Disease
Early phase (n =)	32	22	.2^4-151
CML (n =)	37	16	.09^4-151
Other leukemia (n =)	26	15
Conditioning regimen
With ATG (yes, n =)	43	27	.4^4-151
With TBI (yes, n =)	32	12	.9^4-151
Transplant
Cells (×10⁸/kg)	3.7 (0.9-11.31)	3.3 (0.9-12.0)	.5^4-150

Median follow-up (d)
Surviving patients	740 (41-2155)	895 (143-1965)	.2^4-150
Deceased patients	125 (21-1303)	84 (8-1483)	.5^4-150

	No substitution at position 116	Substitution at position 116	P
Patients
No.	63	37
Median age (y)	26	29	.6^4-150
Donors
Median age (y)	37	39	.2^4-150
Interval diagnosis-transplantation (d)	868	833	.6^4-150
Disease
Early phase (n =)	32	22	.2^4-151
CML (n =)	37	16	.09^4-151
Other leukemia (n =)	26	15
Conditioning regimen
With ATG (yes, n =)	43	27	.4^4-151
With TBI (yes, n =)	32	12	.9^4-151
Transplant
Cells (×10⁸/kg)	3.7 (0.9-11.31)	3.3 (0.9-12.0)	.5^4-150

Median follow-up (d)
Surviving patients	740 (41-2155)	895 (143-1965)	.2^4-150
Deceased patients	125 (21-1303)	84 (8-1483)	.5^4-150

Student t test.

Fisher 2 × 2 exact test.